eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

CSL Behring UK Limited
Hayworth House, Market Place, Haywards Heath, West Sussex, RH16 1DB, UK
Telephone: +44 (0)1444 447 400
Fax: +44 (0)1444 447 403
WWW: http://www.cslbehring.co.uk
Medical Information Direct Line: +44 (0)1444 447 405
Medical Information e-mail: medinfo@cslbehring.com
Customer Care direct line: +44 (0)1444 447 402
Out of Hours contact: +44 (0)1444 447 405

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/08/2011
PIL Privigen 100mg/ml solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 15/03/2011 and displayed until 03/08/2011
Reasons for adding or updating:
  • Extra statutory information
Updated on 31/01/2011 and displayed until 15/03/2011
Reasons for adding or updating:
  • Extra statutory information
Updated on 16/09/2010 and displayed until 31/01/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/04/2010 and displayed until 16/09/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to information for healthcare professionals
Updated on 12/06/2009 and displayed until 23/04/2010
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 17/02/2009 and displayed until 12/06/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/12/2008 and displayed until 17/02/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  human normal immunoglobulin